The effects of anesthesia on measures of nerve conduction velocity in male C57B16/J mice

被引:54
作者
Oh, Sang Su [1 ]
Hayes, John M. [1 ]
Sims-Robinson, Catrina [1 ]
Sullivan, Kelli A. [1 ]
Feldman, Eva L. [1 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Sciatic nerve; Sural nerve; Isoflurane; 2-2-2; Tribromoethanol; Surface temperature; FENTANYL-DROPERIDOL DROPERIDOL; DIABETIC-NEUROPATHY; KETAMINE-XYLAZINE; GENERAL-ANESTHETICS; CARDIAC-FUNCTION; MOUSE MODELS; TRIBROMOETHANOL; HYPERGLYCEMIA; ISOFLURANE; MANAGEMENT;
D O I
10.1016/j.neulet.2010.07.076
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Animal models, particularly mice, are used extensively to investigate neurological diseases. Basic research regarding animal models of human neurological disease requires that the animals exhibit hall mark characteristics of the disease. These include disease specific anatomical, metabolic and behavioral changes. Nerve conduction velocity (NCV) is the predominant method used to assess peripheral nerve health. Normative data adjusted for age, gender and height is available for human patients; however, these data are not available for most rodents including mice. NCV may be affected by animal age and size, body temperature, stimulus strength and anesthesia. While the effects of temperature, age and size are documented, the direct and indirect effects of anesthesia on NCV are not well reported. Our laboratory is primarily concerned with animal models of diabetic neuropathy (DN) and uses NCV to confirm the presence of neuropathy. To ensure that subtle changes in NCV are reliably assayed and not directly or indirectly affected by anesthesia, we compared the effects of 4 commonly used anesthetics, isoflurane, ketamine/xylazine, sodium pentobarbital and 2-2-2 tribromoethanol on NCV in a commonly used rodent model, the C57B16/j mouse. Our results indicate that of the anesthetics tested, isoflurane has minimal impact on NCV and is the safest, most effective method of anesthesia. Our data strongly suggest that isoflurane should become the anesthetic of choice when performing NCV on murine models of neurological disease. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 38 条
  • [11] Kimura J., 1989, Electrodiagnosis in diseases of nerve and muscle: principles and practice, V2nd
  • [12] DOPAMINE AGONISTS IN THE TREATMENT OF DYSTONIA
    LANG, AE
    [J]. CLINICAL NEUROPHARMACOLOGY, 1985, 8 (01) : 38 - 57
  • [13] Management of Chronic Pain in Cancer Survivors
    Levy, Michael H.
    Chwistek, Marcin
    Mehta, Rohtesh S.
    [J]. CANCER JOURNAL, 2008, 14 (06) : 401 - 409
  • [14] Lieggi CC, 2005, CONTEMP TOP LAB ANIM, V44, P11
  • [15] Toxic neuropathies associated with pharmaceutic and industrial agents
    London, Zachary
    Albers, James W.
    [J]. NEUROLOGIC CLINICS, 2007, 25 (01) : 257 - +
  • [16] Mahmood D, 2009, J PHARM PHARMACOL, V61, P1137, DOI [10.1211/jpp.61.09.0002, 10.1211/jpp/61.09.0002]
  • [17] The effect of hyperglycemia on nerve conduction and structure is age dependent
    Malone, JI
    Lowitt, S
    Korthals, JK
    Salem, A
    Miranda, C
    [J]. DIABETES, 1996, 45 (02) : 209 - 215
  • [18] Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice
    Ng, DTF
    Lee, FK
    Song, ZT
    Calcutt, NA
    Lee, LW
    Chung, SSM
    Chung, SK
    [J]. DIABETES, 1998, 47 (06) : 961 - 966
  • [19] Role for nitrosative stress in diabetic neuropathy:: evidence from studies with a peroxynitrite decomposition catalyst
    Obrosova, IG
    Mabley, JG
    Zsengellér, Z
    Charniauskaya, T
    Abatan, OI
    Groves, JT
    Szabó, C
    [J]. FASEB JOURNAL, 2004, 18 (15) : 401 - +
  • [20] Role of poly(ADP-Ribose) polymerase activation in diabetic neuropathy
    Obrosova, IG
    Li, F
    Abatan, OI
    Forsell, MA
    Komjáti, K
    Pacher, P
    Szabó, C
    Stevens, MJ
    [J]. DIABETES, 2004, 53 (03) : 711 - 720